Aurora Cannabis

Yeah, no, exactly.

And then maybe on the ugly side, I mean, I'm not sure if people have been following the hostile takeover bid for Aurora Cannabis by Curaleaf, which is the largest U.S. player in the cannabis space.

It's been pretty entertaining.

Basically, Curaleaf came out and they made an offer for Aurora that the board disagreed with.

I mean, I mean, Boris says they are on Twitter.

Um, I will say this, um, uh, this is Aurora Cannabis, uh, which trades on Nasdaq.

Our story broke at 10:00 AM, uh, [motor humming] so here.

Um, so they have, you know, they're up .23% today.

It's involving latest in Curaleaf and Aurora.

Curaleaf announced it's filing a notice of variation and change to increase its offer to Aurora Cannabis to a total implied consideration of $5 per Aurora share.

That's 25% up from the original offer, which is good.

The new mix is 0.4013 Curaleaf shares plus a dollar in cash, and cas- cash consideration up to 33% from the original 75 cents, and now representing about 20% of- Of the total consideration.

So you can understand why the management team is, uh, flailing.

I'll call it that.

Taking the mindset of a CEO for Aurora Cannabis, they wanna keep their high-paying jobs, but if they were to make this deal happen, like how would you structure something for you for the company, even for you personally, if you're getting a lot of money? Like, how are you highlighting-

They, they don't, they, they don't have that driver's seat really.

So an interesting story there.

Okay, let's now move back to North America and more specifically Canada, where the battle between Cureleaf and Aurora Cannabis, it's getting even louder.

I'm saying this every single week over the past two months.

So the latest, Cureleaf has now gone to the Alberta Securities Commission.

I'm your host, Shad Dales.

Big podcast here today, as we know, Curaleaf trying to acquire Aurora Cannabis.

We know how this has all unfolded in the last couple of weeks.

This has gone public, and it's probably the first M&A deal, if it gets done, that we've seen in over five years.

As well, Virginia released its first draft of regulations for its upcoming adult use market.

And the battle between Cureleaf and Aurora Cannabis, well, it continues to get even more hostile.

On the psychedelic front, what a week it was for Compass Pathways, who delivered another significant update from its Phase 3 program.

So lots to get into here in our latest Trade to Black Weekly Recap presented by Free.

And this is big because we know Georgia has been looking at expanding patient access and federal Schedule 3 reform could eventually create entirely new discussions surrounding interstate or federal delivery frameworks.

So all big news in the right direction.

Let's now move to the business front and yet another chapter in the increasingly hostile takeover between Cureleaf and Aurora Cannabis.

And I mean big.

It's happening right now.

Curaleaf has a hostile takeover bid for Aurora Cannabis that's out there.

I think it's $272 million.

Trulief just listed on the New York Stock Exchange.